Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7MSJ

The crystal structure of mouse HVEM

Summary for 7MSJ
Entry DOI10.2210/pdb7msj/pdb
DescriptorTumor necrosis factor receptor superfamily member 14, SULFATE ION (3 entities in total)
Functional Keywordsimmunity, n-glycosylation, membrane, secreted protein, cytokine, cysteine rich domain, signaling, cell membrane, immune system, tnf receptor
Biological sourceMus musculus (Mouse)
Total number of polymer chains1
Total formula weight12693.14
Authors
Liu, W.,Ramagopal, U.,Garrett-Thompson, S.C.,Fedorov, E.,Bonanno, J.B.,Almo, S.C. (deposition date: 2021-05-11, release date: 2021-10-27, Last modification date: 2024-10-23)
Primary citationLiu, W.,Chou, T.F.,Garrett-Thomson, S.C.,Seo, G.Y.,Fedorov, E.,Ramagopal, U.A.,Bonanno, J.B.,Wang, Q.,Kim, K.,Garforth, S.J.,Kakugawa, K.,Cheroutre, H.,Kronenberg, M.,Almo, S.C.
HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.
J.Exp.Med., 218:-, 2021
Cited by
PubMed Abstract: HVEM is a TNF (tumor necrosis factor) receptor contributing to a broad range of immune functions involving diverse cell types. It interacts with a TNF ligand, LIGHT, and immunoglobulin (Ig) superfamily members BTLA and CD160. Assessing the functional impact of HVEM binding to specific ligands in different settings has been complicated by the multiple interactions of HVEM and HVEM binding partners. To dissect the molecular basis for multiple functions, we determined crystal structures that reveal the distinct HVEM surfaces that engage LIGHT or BTLA/CD160, including the human HVEM-LIGHT-CD160 ternary complex, with HVEM interacting simultaneously with both binding partners. Based on these structures, we generated mouse HVEM mutants that selectively recognized either the TNF or Ig ligands in vitro. Knockin mice expressing these muteins maintain expression of all the proteins in the HVEM network, yet they demonstrate selective functions for LIGHT in the clearance of bacteria in the intestine and for the Ig ligands in the amelioration of liver inflammation.
PubMed: 34709351
DOI: 10.1084/jem.20211112
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon